基于血清和粪便生物标志物的便秘型肠易激综合征患者亚组中的胆汁酸缺乏
一项回顾性研究比较45例便秘型肠易激综合征(IBS-C)患者与184名对照者的血清C4、FGF19及48小时粪便胆汁酸水平,发现约15%的IBS-C患者粪便总胆汁酸和脱氧胆酸降低,且粪便胆汁酸排泄减少与结肠传输减慢相关。
要点
- 45例IBS-C患者中2例血清C4降低、4/43例血清FGF19升高、6/39例48小时粪便胆汁酸降低。
- IBS-C患者粪便石胆酸比例较对照显著升高(P = .04),脱氧胆酸较对照降低(P = .03)。
- IBS-C患者血清C4与FGF19呈负相关,48小时粪便胆汁酸、结肠传输与血清C4、FGF19之间存在相关性。
核心结论
- 约15%的IBS-C患者在每日100 g脂肪饮食下48小时粪便总胆汁酸和脱氧胆酸降低,且粪便胆汁酸排泄降低与结肠传输减慢相关。
研究设计与样本
- 回顾性研究,纳入45例IBS-C患者和184名对照者。
- 对照者中估算空腹血清C4的第10百分位(n = 184)、48小时粪便胆汁酸的第10百分位(n = 46)以及空腹血清FGF19的第90百分位(n = 50)。
- 患者结肠传输采用经验证的门控闪烁显像法测定,数据分析采用Spearman相关性分析。
主要发现
- 45例IBS-C患者中2例血清C4降低,43例中4例血清FGF19升高,39例中6例48小时粪便胆汁酸降低。
- IBS-C患者粪便石胆酸比例较对照显著升高(P = .04),脱氧胆酸较对照降低(P = .03)。
- IBS-C患者血清C4与FGF19呈负相关,48小时粪便胆汁酸、结肠传输与血清C4、FGF19之间存在相关性。
关键数值与推荐
- 对照者空腹血清C4第10百分位(n = 184)、48小时粪便胆汁酸第10百分位(n = 46)、空腹血清FGF19第90百分位(n = 50)作为参考阈值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Short-term administration of delayed-release chenodeoxycholic acid to patients with irritable bowel syndrome with constipation (IBS-C) accelerates colonic transit and reduces symptoms. A preliminary study has shown that patients with IBS-C have reduced levels of bile acids (BAs) in feces and reduced synthesis of BA. We compared the levels of primary and secondary BAs in fecal samples collected over a 48-hour period from patients with IBS-C on a diet that contained 100 g fat per day, and compared them with levels in samples from healthy volunteers (controls). We also examined the relationship between overall colonic transit and biomarkers of BAs in patients with IBS-C. METHODS: We performed a retrospective study of 45 patients with IBS-C and 184 controls. For controls, we estimated the 10th percentile of fasting serum levels of 7α-hydroxy-4-cholesten-3-one (C4, n = 184) and 48-hour fecal BAs (n = 46), and the 90th percentile of the fasting serum level of fibroblast growth factor 19 (FGF19, n = 50). Colonic transit was measured in patients using a validated scintigraphic method. Data from patients with IBS-C were analyzed using Spearman correlations to determine the relationships among levels of C4, FGF19, fecal BAs, and colonic transit. RESULTS: Among the patients with IBS-C, 2 of 45 had low serum levels of C4, 4 of 43 had increased serum levels of FGF19, and 6 of 39 had low levels of BAs in feces collected over 48 hours. Patients with IBS-C had a significant increase in the proportions of fecal lithocholic acid compared with controls (P = .04), and a decrease in deoxycholic acid compared with controls (P = .03). In patients with IBS-C, there were inverse relationships between serum levels of C4 and FGF19 and correlations among levels of 48-hour fecal BAs, colonic transit, and serum C4 and FGF19. CONCLUSIONS: Approximately 15% of patients with IBS-C have reduced total BAs and level of deoxycholic acid in fecal samples collected over 48 hours on a 100 g fat diet. In these patients, lower levels of excretion of BAs into feces correlated with slower colonic transit.
引用
- Vijayvargiya P, Busciglio I, Burton D, et al. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples. Clin Gastroenterol Hepatol. 2017. PMID: 28666948. doi:10.1016/j.cgh.2017.06.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。